BANK OF MONTREAL /CAN/ - STRONGBRIDGE BIOPHARMA PLC ownership

STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 50 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q3 2021. The put-call ratio across all filers is 2.09 and the average weighting 0.3%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of STRONGBRIDGE BIOPHARMA PLC
ValueSharesWeighting
Q2 2021$1,202,000
+123.8%
399,192
+99.3%
0.00%
Q1 2021$537,000
-33.0%
200,317
-23.7%
0.00%
-100.0%
Q4 2020$802,000
+112.2%
262,496
+49.0%
0.00%
Q3 2020$378,000
+2807.7%
176,203
+4820.5%
0.00%
Q2 2020$13,000
+333.3%
3,581
+162.5%
0.00%
Q1 2020$3,000
-97.8%
1,364
-97.9%
0.00%
Q4 2019$139,000
+1290.0%
66,486
+1523.2%
0.00%
Q3 2019$10,000
+11.1%
4,096
+35.6%
0.00%
Q2 2019$9,0003,0210.00%
Other shareholders
STRONGBRIDGE BIOPHARMA PLC shareholders Q3 2021
NameSharesValueWeighting ↓
CAXTON CORP 6,612,065$12,497,00013.66%
Ikarian Capital, LLC 3,392,787$6,412,0000.48%
NEA Management Company, LLC 4,141,308$7,827,0000.41%
Alambic Investment Management, L.P. 61,764$117,0000.28%
KNOTT DAVID M 181,800$344,0000.22%
683 Capital Management, LLC 917,942$1,736,0000.10%
Hudson Bay Capital Management LP 1,409,419$2,664,0000.07%
BOOTHBAY FUND MANAGEMENT, LLC 388,309$734,0000.06%
&PARTNERS 15,000$28,0000.04%
Diversified Trust Co 198,534$375,0000.02%
View complete list of STRONGBRIDGE BIOPHARMA PLC shareholders